Literature DB >> 18836463

Surgical management of benign prostatic hyperplasia: current evidence.

Abdulaziz Baazeem1, Mostafa M Elhilali.   

Abstract

Benign prostatic hyperplasia (BPH) is one of the most common male urological disorders. The surgical management of BPH is evolving at a rapid rate, with several new procedures available that challenge transurethral resection of the prostate as the standard treatment in the surgical management of small to medium sized glands. The new procedures aim to achieve results comparable to transurethral resection of the prostate while minimizing morbidity and cost. In this Review, we discuss some of the current surgical options for the treatment of BPH that seem popular in the literature.

Entities:  

Mesh:

Year:  2008        PMID: 18836463     DOI: 10.1038/ncpuro1214

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  12 in total

1.  Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography.

Authors:  Tiago Bilhim; João M Pisco; Andrea Furtado; Diogo Casal; Diogo Pais; Luís Campos Pinheiro; João E G O'Neill
Journal:  Eur Radiol       Date:  2010-11-30       Impact factor: 5.315

Review 2.  The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis.

Authors:  Yuanshan Cui; Huantao Zong; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2012-08-24       Impact factor: 2.370

3.  A multicentre single-blind randomized controlled trial comparing bipolar and monopolar transurethral resection of the prostate.

Authors:  Carlos E Méndez-Probst; Linda Nott; Stephen E Pautler; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 4.  A Practical Approach for Primary Care Practitioners to Evaluate and Manage Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia.

Authors:  Bruce W Sperry; Stephen Summers; Darshan Patel; Morgan Garcia; Catherine Bandeko
Journal:  Fed Pract       Date:  2021-12-12

5.  Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.

Authors:  Joao Martins Pisco; Hugo Rio Tinto; Luís Campos Pinheiro; Tiago Bilhim; Marisa Duarte; Lúcia Fernandes; José Pereira; António G Oliveira
Journal:  Eur Radiol       Date:  2013-01-31       Impact factor: 5.315

6.  Effect of superselective prostatic artery embolization on benign prostatic hyperplasia.

Authors:  Yi Tang; Jian-Hui Zhang; Yao-Bin Zhu; Shao-Jie Wu; Sen-Lin Cai; Yan-Feng Zhou; Xin Qian; Jie-Wei Luo; Zhu-Ting Fang
Journal:  Abdom Radiol (NY)       Date:  2020-10-06

7.  Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.

Authors:  Maurizio Grosso; Alberto Balderi; Matteo Arnò; Davide Sortino; Alberto Antonietti; Fulvio Pedrazzini; Grazia Giovinazzo; Claudia Vinay; Orazio Maugeri; Carlo Ambruosi; Giuseppe Arena
Journal:  Radiol Med       Date:  2014-09-23       Impact factor: 3.469

8.  Efficacy and safety of tamsulosin for treating lower urinary tract symptoms associated with benign prostatic hyperplasia: a multicenter, randomized, controlled, open-label non-inferiority study.

Authors:  Hyo Serk Lee; Sae Woong Kim; Seung-June Oh; Myung-Soo Choo; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2012-03-19

9.  Clinical evaluation of embolization of the superior vesical prostatic artery for treatment of benign prostatic hyperplasia: a single-center retrospective study.

Authors:  Zhilei Qiu; Changcun Zhang; Xinsheng Wang; Kai Cheng; Xin Liang; Dawen Wang; Sichuan Hou; Xinsheng Wang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-12-29       Impact factor: 1.195

10.  Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate.

Authors:  Huang Tao; Yu Yong Jiang; Qi Jun; Xu Ding; Duan Liu Jian; Ding Jie; Zhu Yu Ping
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.